N
Patient 1
ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT AFP | ALPHA-FETOPROTEIN | ABBOTT IRELAND | LOK | 03P36-25 | 91429FN00 | Y | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2019-02-18 | 0 |
Patient 1
ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
Patient 1
THE CUSTOMER OBSERVED DISCREPANT ALPHA 1 FETOPROTEIN (AFP) RESULTS ON THE ARCHITECT ANALYZER. THE FOLLOWING DATA PROVIDED: INITIAL 14, REPEATS 10, 20 FOR A PATIENT BETWEEN THE AGES OF 1 AND 3 YEARS OLD. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.